~80 ng/mL by age 60 (60% decline) CLINICAL PROGRAMS NCT05239615 (topical for photoaging, Phase II, completed 2024)
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
Kumar, P., Liu, C., Suliburk, J., Hsu, J.W., Muthupillai, R., Jahoor, F., Minard, C.G., Taffet, G.E., and Sekhar, R.V
Additionally, the knockdown of YY1 decreases the protective effects of resveratrol (an agonist of SIRT1) on EMT and fibrosis in db/db mice (Du et al., 2021)
Gastrointestinal Effects The most commonly reported adverse effects are gastrointestinal in nature, including: Nausea and vomiting (affecting 20-40% of patients initially, varying by agent and dose) [8] Diarrhoea or constipation Abdominal discomfort and bloating Reduced appetite In elderly patients, persistent nausea and vomiting can lead to dehydration and electrolyte imbalances more rapidly than in younger adults